New-onset diabetes after kidney transplantation:: Risk factors

被引：138

作者：

Rodrigo, Emilio ^{[1
]}

Fernandez-Fresnedo, Gema ^{[1
]}

Valero, Rosalia ^{[1
]}

Ruiz, Juan Carlos ^{[1
]}

Pinera, Celestino ^{[1
]}

Palomar, Rosa ^{[1
]}

Gonzalez-Cotorruelo, Julio ^{[1
]}

Gomez-Alamillo, Carlos ^{[1
]}

Arias, Manuel ^{[1
]}

机构：

[1] Univ Cantabria, Serv Nephrol, Santander 39008, Spain

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷

关键词：

D O I：

10.1681/ASN.2006080929

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

New-onset diabetes after transplantation (NODAT) contributes to the risk for cardiovascular disease and infection, reducing graft and patient survival. For improvement of the outcome of kidney transplant recipients, it is of great interest to know precisely the risk factors that contribute to NODAT development. Nonmodifiable risk factors for development of NODAT are age, race, genetic background, family history of diabetes, and previous glucose intolerance. Modifiable risk factors are obesity and overweight, hepatitis C virus and cytomegalovirus infections, and immunosuppressive drugs. Both steroids and calcineurin inhibitors influence the appearance of NODAT, whereas the role of sirolimus in glucose metabolism currently is controversial.

引用

页码：S291 / S295

页数：5

共 50 条

[21] Proportion of Veillonella and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation
Eun, K. Ji
Kim, H.
Cho, H.
Park, J.
Lee, J.
Kim, D.
Joo, K.
Kim, Y.
Lee, H.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1001 - 1001
[22] Validation of a Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation
Chakkera, Harini A.
Chang, Yu-Hui
Ayub, Asad
Gonwa, Thomas A.
Weil, E. Jennifer
Knowler, William C.
[J]. DIABETES CARE, 2013, 36 (10) : 2881 - 2886
[23] Insulin Resistance as a Risk Factor for New-Onset Diabetes After Kidney Transplantation
Tokodai, K.
Amada, N.
Haga, I.
Takayama, T.
Nakamura, A.
Kashiwadate, T.
[J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (02) : 537 - 539
[24] PROPORTION OF VEILLONELLA AND THE RISK OF NEW-ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION
Kim, Ji Eun
Kim, Hyo-Eun
Cho, Hyunjeong
Park, Ji In
Lee, Jung Pyo
Kim, Dong Ki
Joo, Kwon Wook
Kim, Yon Su
Lee, Hajeong
[J]. TRANSPLANTATION, 2020, 104 (09) : S190 - S190
[25] Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
Zelle, Dorien M.
Corpeleijn, Eva
Deinum, Jolijn
Stolk, Ronald P.
Gans, Rijk O. B.
Navis, Gerjan
Bakker, Stephan J. L.
[J]. DIABETES CARE, 2013, 36 (07) : 1926 - 1932
[26] Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation
Hamer, Rizwan A.
Chow, Chern L.
Ong, Albert C. M.
McKane, William S.
[J]. TRANSPLANTATION, 2007, 83 (01) : 36 - 40
[27] Pretransplantation Risk Factors Associated With New-onset Diabetes After Living-donor Kidney Transplantation
Xie, L.
Tang, W.
Wang, X.
Wang, L.
Lu, Y.
Lin, T.
[J]. TRANSPLANTATION PROCEEDINGS, 2016, 48 (10) : 3299 - 3302
[28] Genetic and Clinical Risk Factors of New-Onset Diabetes After Transplantation in Hispanic Kidney Transplant Recipients
Yang, Jaewook
Hutchinson, Ian I.
Shah, Tariq
Min, David I.
[J]. TRANSPLANTATION, 2011, 91 (10) : 1114 - 1119
[29] New-onset gout after kidney transplantation: Incidence, risk factors and implications
Abbott, KC
Kimmel, PL
Dharnidharka, V
Oglesby, RJ
Agodoa, LY
Caillard, S
[J]. TRANSPLANTATION, 2005, 80 (10) : 1383 - 1391
[30] Early Steroid Withdrawal After Kidney Transplantation in Patients at Risk for New-Onset Diabetes After Transplantation
Gierczak, Valentine
Noble, Johan
Malvezzi, Paolo
Janbon, Benedicte
Terrec, Florian
Chevallier, Eloi
Bennani, Hamza Naciri
Bugnazet, Mathilde
Imerzoukene, Farida
Rostaing, Lionel
Jouve, Thomas
[J]. TRANSPLANTATION PROCEEDINGS, 2021, 53 (07) : 2216 - 2226

← 1 2 3 4 5 →